Literature DB >> 20657789

Screening for Barrett's Esophagus.

Matt Atkinson1, Amitabh Chak.   

Abstract

Barrett's esophagus (BE) increases the risk for development of esophageal adenocarcinoma. Because of the rapid rise in incidence of esophageal adenocarcinoma, screening for BE with subsequent surveillance when found has been proposed as a method of early detection. Sedated endoscopy, however, is too expensive for wide spread screening. As a result, other techniques including unsedated transnasal esophagoscopy and capsule esophagoscopy have been proposed to expand screening programs.

Entities:  

Year:  2010        PMID: 20657789      PMCID: PMC2906782          DOI: 10.1016/j.tgie.2010.02.009

Source DB:  PubMed          Journal:  Tech Gastrointest Endosc        ISSN: 1096-2883


  43 in total

1.  Which landmark results in a more consistent diagnosis of Barrett's esophagus, the gastric folds or the palisade vessels?

Authors:  Yuji Amano; Norihisa Ishimura; Kenji Furuta; Yoshiko Takahashi; Daisuke Chinuki; Yoshiyuki Mishima; Ichiro Moriyama; Hiroyuki Fukuhara; Shunji Ishihara; Kyoichi Adachi; Yoshikazu Kinoshita
Journal:  Gastrointest Endosc       Date:  2006-08       Impact factor: 9.427

2.  Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett's esophagus: a randomized and blinded comparison.

Authors:  Blair A Jobe; John G Hunter; Eugene Y Chang; Charles Y Kim; Glenn M Eisen; Jedediah D Robinson; Brian S Diggs; Robert W O'Rourke; Anne E Rader; Paul Schipper; David A Sauer; Jeffrey H Peters; David A Lieberman; Cynthia D Morris
Journal:  Am J Gastroenterol       Date:  2006-12       Impact factor: 10.864

3.  Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Authors:  Kenneth K Wang; Richard E Sampliner
Journal:  Am J Gastroenterol       Date:  2008-03       Impact factor: 10.864

4.  Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia.

Authors:  Amitabh Chak; Ashley Faulx; Charis Eng; William Grady; Margaret Kinnard; Heather Ochs-Balcom; Gary Falk
Journal:  Cancer       Date:  2006-11-01       Impact factor: 6.860

5.  Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia.

Authors:  W H Chow; W J Blot; T L Vaughan; H A Risch; M D Gammon; J L Stanford; R Dubrow; J B Schoenberg; S T Mayne; D C Farrow; H Ahsan; A B West; H Rotterdam; S Niwa; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1998-01-21       Impact factor: 13.506

6.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria.

Authors:  Prateek Sharma; John Dent; David Armstrong; Jacques J G H M Bergman; Liebwin Gossner; Yoshio Hoshihara; Janusz A Jankowski; Ola Junghard; Lars Lundell; Guido N J Tytgat; Michael Vieth
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

7.  Adenocarcinoma of the esophagus: role of obesity and diet.

Authors:  L M Brown; C A Swanson; G Gridley; G M Swanson; J B Schoenberg; R S Greenberg; D T Silverman; L M Pottern; R B Hayes; A G Schwartz
Journal:  J Natl Cancer Inst       Date:  1995-01-18       Impact factor: 13.506

8.  Capsule endoscopy for the detection of oesophageal mucosal disorders: a comparison of two different ingestion protocols.

Authors:  Pieter J F De Jonge; Brechje C Van Eijck; Han Geldof; Frank C Bekkering; Marie-Louise Essink-Bot; Suzanne Polinder; Ernst J Kuipers; Peter D Siersema
Journal:  Scand J Gastroenterol       Date:  2008       Impact factor: 2.423

9.  Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease.

Authors:  Lauren B Gerson; Peter W Groeneveld; George Triadafilopoulos
Journal:  Clin Gastroenterol Hepatol       Date:  2004-10       Impact factor: 11.382

10.  Cost-benefit analysis of capsule endoscopy compared with standard upper endoscopy for the detection of Barrett's esophagus.

Authors:  Lauren Gerson; Otto S Lin
Journal:  Clin Gastroenterol Hepatol       Date:  2007-03       Impact factor: 11.382

View more
  4 in total

1.  [The possibilities of reflux disease diagnosis by the ear, nose and throat specialist].

Authors:  P Jecker
Journal:  HNO       Date:  2012-03       Impact factor: 1.284

Review 2.  Diagnosis and management of Barrett's esophagus.

Authors:  Eric M Nelsen; Robert H Hawes; Prasad G Iyer
Journal:  Surg Clin North Am       Date:  2012-08-20       Impact factor: 2.741

3.  Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?

Authors:  Carmine Finelli; Giovanni Tarantino
Journal:  Hepatol Int       Date:  2012-10-26       Impact factor: 6.047

4.  Clinical and psychosocial variables associated with behavioral intentions to undergo surveillance endoscopy.

Authors:  John M Hollier; Marilyn Hinojosa-Lindsey; Shubhada Sansgiry; Hashem B El-Serag; Aanand D Naik
Journal:  BMC Gastroenterol       Date:  2014-06-10       Impact factor: 3.067

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.